UNRESECTABLE COLORECTAL CARCINOMA
Clinical trials for UNRESECTABLE COLORECTAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE COLORECTAL CARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE COLORECTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early trial tests new drug combo for Tough-to-Treat cancers
Disease control OngoingThis early-stage study aims to find the safest and most effective dose of a new drug, M6620, when given with the chemotherapy drug irinotecan. It is for adults with advanced solid tumors, like certain colorectal, pancreatic, or lung cancers, that have spread or cannot be removed …
Matched conditions: UNRESECTABLE COLORECTAL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Personalized immune cells tested to fight five tough cancers
Disease control TerminatedThis early-stage study aimed to test the safety and early effectiveness of a personalized cell therapy called STIL101. The therapy involved growing a patient's own cancer-fighting immune cells (T-cells) from a tumor sample in a lab and then infusing them back. It was designed for…
Matched conditions: UNRESECTABLE COLORECTAL CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for Tough-to-Treat colon cancer patients
Disease control OngoingThis early-stage trial is testing whether combining existing cancer drugs with a new experimental drug (LY3214996) can help control advanced colorectal cancer that has stopped responding to standard treatments. The study aims to find safe doses and see if these combinations can s…
Matched conditions: UNRESECTABLE COLORECTAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC